KD Logo

Insider Selling: MIGNONE ROBERTO, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] Director divested 519,000 shares

ZOM Stock

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Teva- Pharmaceutical Industries Ltd. ADR shares valued at $8,838,570 were sold by MIGNONE ROBERTO on Jun 18 ’24. At $17.03 per share, MIGNONE ROBERTO sold 519,000 shares. The insider’s holdings dropped to 981,000 shares worth approximately $16.32 million following the completion of this transaction.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Also, Weiss Amir sold 12,635 shares, netting a total of over 210,377 in proceeds. Following the sale of shares at $16.65 each, the insider now holds 5,179 shares.

Before that, Weiss Amir had sold 15,500 shares from its account. In a trade valued at $260,417, the Chief Accounting Officer traded Teva- Pharmaceutical Industries Ltd. ADR shares for $16.80 each. Upon closing the transaction, the insider’s holdings decreased to 15,500 shares, worth approximately $0.3 million.

As published in a research note from JP Morgan on March 08, 2024, Teva- Pharmaceutical Industries Ltd. ADR [TEVA] has been rated up from an Underweight to a Neutral and the price target has been revised to $14. Analysts at Piper Sandler upgraded the stock from ‘”a Neutral”‘ to ‘”an Overweight”‘ outlook in a report released in mid February. As of January 23, 2024, Jefferies has increased its “Hold” rating to a “Buy” for TEVA. Earlier on January 03, 2024, Piper Sandler upgraded its rating. Their new recommendation was “a Neutral” for TEVA stock which previously was a “an Underweight”.

Analyzing TEVA Stock Performance

During the last five days, there has been a surge of approximately 2.40%. Over the course of the year, Teva- Pharmaceutical Industries Ltd. ADR shares have jumped approximately 59.39%. Shares of the company reached a 52-week high of $17.69 on 06/12/24 and a 52-week low of $10.45 on 01/02/24. A 50-day SMA is recorded $16.06, while a 200-day SMA reached $12.40. Nevertheless, trading volume fell to 3.98 million shares from 7.82 million shares the previous day.

Support And Resistance Levels for Teva- Pharmaceutical Industries Ltd. ADR (TEVA)

According to the 24-hour chart, there is a support level at 16.54, which, if violated, would cause prices to drop to 16.26. In the upper region, resistance lies at 16.97. The next price resistance is at 17.13. RSI (Relative Strength Index) is 52.80 on the 14-day chart, showing neutral technical sentiment. Moving Average Convergence Divergence (MACD) is at -0.16, which suggests the price will decrease in the coming days. Percent R is at 36.17%, indicating low price movement. Stochastics %K at holding indicates that the stock is to be held.

Most Popular